Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators aim to demonstrate whether balance, cognition and activities of daily living have changed in COPD patients with and without frailty.
COPD is a common, preventable and treatable disease characterized by progressive respiratory symptoms and airflow limitation. Frailty defines a clinical syndrome characterized by multiple system effects, leading to decreased functional reserve and increased sensitivity to dependence or mortality following minor stress events. Inflammation, lack of physical activity, reduced exercise efficiency and maximum oxygen uptake may contribute to the development of frailty in patients with COPD. Balance, cognition and activities of daily living are associated with COPD.
This study will evaluate the effect of frailty on balance, cognition and activities of daily living in patients with COPD.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Frail patients with COPD | No intervention | ||
| Non-frail patients with COPD | No intervention |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Presence of The Frailty Will Be evaluated Using The Frailty Criteria by Fried | Frailty will be identified by the presence of three or more of the following criteria unintentional weight loss (10 Ibs in past year), weakness (grip strength), self-reported exhaustion, slow walking speed and low physical activity. Patients with three or more of the criteria present were classified as frail. | 1st Day |
| Balance Assessment Using Functional Reach Test | The Functional Reach Test measures how far patient can reach forward from a normal relaxed stance. | 1st Day |
| Cognition Using MoCA-Test | Cognitive function will be evaluated with the secreening tool the Montreal Cognitive Assessment (MoCA). The MoCA is a 30-point screening tool. | 1st Day |
| Perform activities of daily living (ADL) will be evaluated using the Glittre ADL-test | Glittre ADL-test was designed specifically to assess the functional limitation in patients with COPD. Glittre ADL-test time will be considered the main outcome variable, and will be recorded in minutes (metric). | 1st Day |
| Measure | Description | Time Frame |
|---|---|---|
| Exercise Capacity Using 6-Minute Walk Test | The standard protocol of the test is applied in a 30-meter continuous corridor. Standard instructions are given during testing. | 1st Day |
| Disease-Related Quality of Life Assessment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Individuals who are diagnosed with COPD at Hacettepe University and who are referred to the Cardiopulmonary Rehabilitation Unit for physiotherapy also who are willing to participate in the study will be included in the study.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Deniz Inal-Ince, PhD | Hacettepe University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hacettepe University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation | Ankara | Sihhiye | 06100 | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D000073496 | Frailty |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
COPD evaluation test (CAT) was developed to help assess health status.
| 1st Day |
| Respiratory Muscle Strength Assessment | Respiratory muscle strength will be evaluated by non-invasive methods by measuring maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). | 1st Day |
| Shortness of Breath Assessment | Modified Medical Research Council (mMRC) dyspnea scale will be used to determine the shortness of breath severity. | 1st Day |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |